InvestorsHub Logo
Followers 5
Posts 66
Boards Moderated 0
Alias Born 05/02/2016

Re: antihama post# 1605

Wednesday, 03/01/2017 10:26:52 PM

Wednesday, March 01, 2017 10:26:52 PM

Post# of 3283
Something does't add up... The total Melphalan market is probably less than $40 million, possibly less than $30 million. (i.e less than $8 million per quarter). If Evomela is priced at the same pricepoint as generic how could you ever get more than $13 million per quarter?